G37.81: Myelin oligodendrocyte glycoprotein antibody disease
G37.81 is a billable, specific ICD-10-CM code for myelin oligodendrocyte glycoprotein antibody disease. It is valid for submission on a claim.
Check G37.81 with the rest of the claim: free scrubberCode also
Both codes may be needed to describe the encounter fully. Sequencing depends on the reason for the visit.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- MOG antibody disease
Risk adjustment
G37.81 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 198 Multiple Sclerosis0.647 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
G37.81 is named in 8 Medicare coverage policies: 8 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A56612Billing and Coding: CT of the Head
- A56619Billing and Coding: Nerve Conduction Studies and Electromyography
- A56773Billing and Coding: Neurophysiology Evoked Potentials (NEPs)
- A56799Billing and Coding: Visual Fields Testing
Alphabetic index entries that lead here
- MOGAD(myelin oligodendrocyte glycoprotein antibody disease)
- Disease, diseased›MOG antibody
- Disease, diseased›myelin oligodendrocyte glycoprotein antibody
Code history
Unchanged in every release from FY2024 to FY2027.